Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCOGNITO trial in COPD
2016-004473-41Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Sep 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tiotropium + olodaterol and fluticasone propionate + vilanterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University of Dundee. Primary endpoint: Bacterial load of total respiratory pathogens at 6 months. Started Sep 2017; status: completed.
02
Drugs
tiotropium + olodaterolfluticasone propionate + vilanterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2016-004473-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004473-41.